First Time Loading...
C

CTC Bio Inc
KOSDAQ:060590

Watchlist Manager
CTC Bio Inc
KOSDAQ:060590
Watchlist
Price: 7 950 KRW -0.38%
Updated: Jun 11, 2024

Intrinsic Value

CTC Bio, Inc. engages in the manufacture of pharmaceuticals, functional food and animal health products. [ Read More ]

The intrinsic value of one CTC Bio Inc stock under the Base Case scenario is 3 908.28 KRW. Compared to the current market price of 7 950 KRW, CTC Bio Inc is Overvalued by 51%.

Key Points:
Intrinsic Value
Base Case
3 908.28 KRW
Overvaluation 51%
Intrinsic Value
Price
C
Base Case Scenario

Valuation Backtest
CTC Bio Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling CTC Bio Inc stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Ask me anything about
CTC Bio Inc

Provide an overview of the primary business activities
of CTC Bio Inc.

What unique competitive advantages
does CTC Bio Inc hold over its rivals?

What risks and challenges
does CTC Bio Inc face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for CTC Bio Inc.

Provide P/S
for CTC Bio Inc.

Provide P/E
for CTC Bio Inc.

Provide P/OCF
for CTC Bio Inc.

Provide P/FCFE
for CTC Bio Inc.

Provide P/B
for CTC Bio Inc.

Provide EV/S
for CTC Bio Inc.

Provide EV/GP
for CTC Bio Inc.

Provide EV/EBITDA
for CTC Bio Inc.

Provide EV/EBIT
for CTC Bio Inc.

Provide EV/OCF
for CTC Bio Inc.

Provide EV/FCFF
for CTC Bio Inc.

Provide EV/IC
for CTC Bio Inc.

Show me price targets
for CTC Bio Inc made by professional analysts.

What are the Revenue projections
for CTC Bio Inc?

How accurate were the past Revenue estimates
for CTC Bio Inc?

What are the Net Income projections
for CTC Bio Inc?

How accurate were the past Net Income estimates
for CTC Bio Inc?

What are the EPS projections
for CTC Bio Inc?

How accurate were the past EPS estimates
for CTC Bio Inc?

What are the EBIT projections
for CTC Bio Inc?

How accurate were the past EBIT estimates
for CTC Bio Inc?

Compare the revenue forecasts
for CTC Bio Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of CTC Bio Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of CTC Bio Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of CTC Bio Inc compared to its peers.

Compare the P/E ratios
of CTC Bio Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing CTC Bio Inc with its peers.

Analyze the financial leverage
of CTC Bio Inc compared to its main competitors.

Show all profitability ratios
for CTC Bio Inc.

Provide ROE
for CTC Bio Inc.

Provide ROA
for CTC Bio Inc.

Provide ROIC
for CTC Bio Inc.

Provide ROCE
for CTC Bio Inc.

Provide Gross Margin
for CTC Bio Inc.

Provide Operating Margin
for CTC Bio Inc.

Provide Net Margin
for CTC Bio Inc.

Provide FCF Margin
for CTC Bio Inc.

Show all solvency ratios
for CTC Bio Inc.

Provide D/E Ratio
for CTC Bio Inc.

Provide D/A Ratio
for CTC Bio Inc.

Provide Interest Coverage Ratio
for CTC Bio Inc.

Provide Altman Z-Score Ratio
for CTC Bio Inc.

Provide Quick Ratio
for CTC Bio Inc.

Provide Current Ratio
for CTC Bio Inc.

Provide Cash Ratio
for CTC Bio Inc.

What is the historical Revenue growth
over the last 5 years for CTC Bio Inc?

What is the historical Net Income growth
over the last 5 years for CTC Bio Inc?

What is the current Free Cash Flow
of CTC Bio Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for CTC Bio Inc.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
CTC Bio Inc

Current Assets 80.5B
Cash & Short-Term Investments 21.3B
Receivables 25B
Other Current Assets 34.2B
Non-Current Assets 82.1B
Long-Term Investments 1.1B
PP&E 61.9B
Intangibles 11.2B
Other Non-Current Assets 7.9B
Current Liabilities 70.9B
Accounts Payable 6B
Accrued Liabilities 14.6B
Short-Term Debt 29.9B
Other Current Liabilities 20.5B
Non-Current Liabilities 16.4B
Long-Term Debt 3.7B
Other Non-Current Liabilities 12.7B
Efficiency

Earnings Waterfall
CTC Bio Inc

Revenue
135.8B KRW
Cost of Revenue
-90.6B KRW
Gross Profit
45.2B KRW
Operating Expenses
-50.3B KRW
Operating Income
-5.1B KRW
Other Expenses
-9.1B KRW
Net Income
-14.2B KRW

Free Cash Flow Analysis
CTC Bio Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

Profitability Score
Profitability Due Diligence

CTC Bio Inc's profitability score is 42/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Negative Free Cash Flow
Positive 3-Year Average ROIC
ROE is Increasing
42/100
Profitability
Score

CTC Bio Inc's profitability score is 42/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

CTC Bio Inc's solvency score is 42/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Short-Term Solvency
Positive Net Debt
42/100
Solvency
Score

CTC Bio Inc's solvency score is 42/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
CTC Bio Inc

Wall Street analysts forecast CTC Bio Inc stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CTC Bio Inc is 25 000 KRW .

Lowest
Price Target
Not Available
Average
Price Target
25 000 KRW
214% Upside
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Shareholder Return

Price
CTC Bio Inc

1M 1M
-2%
6M 6M
-15%
1Y 1Y
-27%
3Y 3Y
+16%
5Y 5Y
+6%
10Y 10Y
-38%
Annual Price Range
7 950
52w Low
7 780
52w High
14 740
Price Metrics
Average Annual Return -1.8%
Standard Deviation of Annual Returns 26.77%
Max Drawdown -54%
Shares Statistics
Market Capitalization 190.1B KRW
Shares Outstanding 23 908 755
Percentage of Shares Shorted
N/A

Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

CTC Bio Inc

Country

Korea

Industry

Pharmaceuticals

Market Cap

190.1B KRW

Dividend Yield

0%

Description

CTC Bio, Inc. engages in the manufacture of pharmaceuticals, functional food and animal health products. The company is headquartered in Hongcheon, Gangwon-Do. The company went IPO on 2002-02-21. The company pharmaceuticals include anticancer agents, antibiotics, bone injury treatments, antiulcer agents, blood flow stimulants and others. Its veterinary drugs include vaccines, antibiotics, immune enhancers, enzymes, organic acid, avian influenza-related agents and others. Its animal feed supplements include pigments, kapok seed meal, sesame meal and others. Its functional food business includes the development and manufacture of enzymes, lactobacillus and related products mainly used in dairy products. The company also involves in the development of pharmaceutical manufacturing technology and know-how. The firm distributes its products within domestic market and to overseas markets.

Contact

GANGWON-DO
HONGCHEON
6F, 296, Jungdae-ro, Songpa-gu
+8216618800
http://www.ctcbio.com/

IPO

2002-02-21

Employees

-

Officers

Chief Executive Officer
Mr. Mingoo Lee
President
Seong-Rin Kim

See Also

Discover More
What is the Intrinsic Value of one CTC Bio Inc stock?

The intrinsic value of one CTC Bio Inc stock under the Base Case scenario is 3 908.28 KRW.

Is CTC Bio Inc stock undervalued or overvalued?

Compared to the current market price of 7 950 KRW, CTC Bio Inc is Overvalued by 51%.